Data / Form D filings / Synergenetics Bioscience Inc.
Synergenetics Bioscience Inc.: Form D filings
Synergenetics Bioscience Inc., a biotechnology company in Vancouver, British Columbia, Canada, filed 3 Form D notices with the SEC in 2020. The latest, on March 30, 2020, reports $100,000 sold of a $100,000 offering to 1 investor.
Find out what Synergenetics Bioscience Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11001 GRANVILLE AVENUE, Vancouver, British Columbia, Canada, V6Y 1
- Phone
- (604) 773-5180
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1800452
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 30, 2020 | New notice | $100,000 | $100,000 | $0 | 1 | Mar 20, 2020 | sec.gov |
| Jan 28, 2020 | New notice | $300,000 | $300,000 | $0 | 1 | Jan 24, 2020 | sec.gov |
| Jan 22, 2020 | New notice | $2,670 | $2,670 | $0 | 2 | Jan 3, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Chong Chen | Executive Officer | |
| Ping Zhang | Executive Officer, Director | |
| Ling Zhang | Executive Officer, Director |
Every Form D from the week of Mar 30, 2020 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Synergenetics Bioscience Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.